PT - JOURNAL ARTICLE AU - Pokhraj Prakashchandra Suthar AU - Khushboo Gupta AU - Jagadeesh S Singh TI - <sup>18</sup>F-FDG PET/CT imaging features of Cardiac Arrhythmia - induced by Panitumumab AID - 10.2967/jnmt.121.262216 DP - 2021 Jul 01 TA - Journal of Nuclear Medicine Technology PG - jnmt.121.262216 4099 - http://tech.snmjournals.org/content/early/2021/07/30/jnmt.121.262216.short 4100 - http://tech.snmjournals.org/content/early/2021/07/30/jnmt.121.262216.full AB - Panitumumab is a new humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) approved for the treatment of advanced colorectal cancer. There is an increase in the use of this drug due to a good response rate and possible secondary resection in advance colorectal cancer. Here we present 18F-FDG PET/CT imaging findings of cardiac arrhythmia in a patient receiving Panitumumab for the treatment of metastatic infiltrating rectal adenocarcinoma. Cardiotoxicity is a known adverse effect associated with Panitumumab. By far to our knowledge, no documented imaging findings for the same are available in the literature.